Preventable Vaccines Market to Grow at 10.16% CAGR by 2019 Says a New Research Report at Sandlerresearch.org
Dallas, Texas (PRWEB) February 22, 2015 -- Analysts forecast the Global Preventable Vaccines market to grow at a CAGR of 10.16% over the period 2014-2019. According to the report, the primary driving factor is the inclusion of pediatric vaccines in the national immunization schedule of many countries. This helps increase the consumption of vaccines in the market, thereby boosting growth. Various governments are conducting routine immunization schedules to ensure that vaccines are available to both adults and children. Global players are targeting countries like India and China as vaccine development hubs because of the availability of skilled manpower, excellent manufacturing capabilities and low-manufacturing costs. The report Global Preventable Vaccines Market 2015-2019 covers only commercialized vaccines for diseases that are vaccine preventable.
One major trend emerging in the market is the strategic alliances of the vendors in the market, resulting in consolidation. M&A are usually intended to increase the market penetration of the acquirer or to enhance the product portfolio of the parent company. Large pharmaceutical companies are focused on consolidating their position in the Global Preventable Vaccines market. Additionally, vaccine manufacturers are shifting their bases to developing countries in order to capitalize on the favorable business conditions in these countries.
The report recognizes the following companies as the key players in the Global Preventable Vaccines Market: GlaxoSmithKline plc, Merck and Co. Inc., Novartis AG, Pfizer Inc. and Sanofi SA.
Other Prominent Vendors in the market are: Abbott, AstraZeneca, Bavarian Nordic, Baxter, Bharat Biotech, Bharat Immunologicals and Biologicals, bioCSL, Bio Med, Crucell, Dynavax Technologies, Indian Immunologicals, Janssen Pharmaceuticals, Kaketsuken, LG Life Sciences, Lupin, Mitsubishi Tanabe Pharma, Novartis, Nuron, Panacea Biotec, Protein Sciences, Roche, Serum Institute of India, Shenzhen Kangtai Biological Products, Sinovac Biotech, S K Chemicals, Takeda Pharmaceutical, Valeant Pharmaceuticals and Zydus Cadila.
Order a copy of this report at (Prices start at US $3000 for a Single user PDF) http://www.sandlerresearch.org/purchase?rname=31294.
Further, the report states that the inadequate vaccine coverage in the world is a major challenge to the growth of the market. Lack of awareness and negligence among individuals, besides the subsidies offered by governments for a particular age group, are the most prominent factors that decrease these coverage rates.
List of Exhibits:
Exhibit 1: Market Research Methodology
Exhibit 2: Vaccine Approval Process
Exhibit 3: Global Preventable Vaccines Market 2014-2019 (US$ million)
Exhibit 4: Global Preventable Vaccines Market Categories
Exhibit 5: Global Adult and Pediatric Preventable Vaccine Market Share 2014-2019 (US$ million)
Exhibit 6: Global Preventable Vaccines Market Share by Vaccine Type 2014 and 2019
Exhibit 7: Global Preventable Vaccines Market Segmentation by Type of Vaccine
Exhibit 8: Global Preventable Vaccines Market Segmentation by Product Type
Exhibit 9: Global Preventable Vaccines Market by Geographical Segmentation 2014
Exhibit 10: Global Preventable Vaccines Market by Region 2014-2019 (US$ million)
Exhibit 11: Global Preventable Vaccines Market in the US 2014-2019 (US$ million)
Exhibit 12: Global Preventable Vaccines Market in the EU 2014-2019 (US$ million)
Exhibit 13: Global Preventable Vaccines Market in Japan 2014-2019 (US$ million)
Exhibit 14: Global Preventable Vaccines Market in India 2014-2019 (US$ million)
Exhibit 15: Global Preventable Vaccines Market in China 2014-2019 (US$ million)
Exhibit 16: Global Pediatric Preventable Vaccines Market 2014-2019 (US$ million)
Exhibit 17: Global Pediatric Preventable Vaccines Market Segmentation
Exhibit 18: Global Pediatric Hepatitis Vaccines Market 2014-2019 (US$ million)
Exhibit 19: Global Pediatric Haemophilus Influenzae Type B Vaccines Market 2014-2019 (US$ million)
Exhibit 20: Global Pediatric MMR Vaccine Market 2014-2019 (US$ million)
Exhibit 21: Global Pediatric Combination Vaccines Market 2014-2019 (US$ million)
Exhibit 22: Global Pediatric Pneumococcal Vaccines Market 2014-2019 (US$ million)
Exhibit 23: Global Polio Vaccines Market 2014-2019 (US$ million)
Exhibit 24: Global Pediatric Varicella Vaccines Market 2014-2019 (US$ million)
Exhibit 25: Global Other Pediatric Vaccines Market 2014-2019 (US$ million)
Explore other new reports on Pharmaceutical Sector.
About US
Sandlerresearch.org is an online market research store for research reports on multiple industries. These reports provide market analysis, trends and opportunities and forecast about industries that helps to make a right decision for the business.
Ritesh Tiwari, Sandlerresearch.org, http://www.sandlerresearch.org/, +1 (888) 391-5441, [email protected]
Share this article